¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå, ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ¹æ»ç¼± À¯Çüº°, Ä¡·áº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ¿¹Ãø(2025-2034³â)
Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1762365
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 130 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,900,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,288,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,676,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é Á¾¾çÇÐ ºÐ¾ß ¹æ»ç¼± Ä¡·á ¼¼°è ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 154¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Á¾¾çÇÐ ºÐ¾ßÀÇ ¹æ»ç¼± Ä¡·á ½ÃÀåÀº ¾Ï Ä¡·á ¹× °ü¸®¸¦ À§ÇÑ °í¿¡³ÊÁö ÀÌ¿ÂÈ­ ¹æ»ç¼±ÀÇ È°¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ Ä¡·á¹ý¿¡¼­´Â ÁÖº¯ °Ç°­ÇÑ Á¶Á÷°ú Àå±âÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¾Ï¼¼Æ÷ÀÇ ¹Ú¸ê°ú Áõ½Ä ¾ïÁ¦¸¦ ¸ñÀûÀ¸·Î ¾Ç¼º Á¾¾ç¿¡ Á¤È®ÇÏ°Ô ¹æ»ç¼±À» Á¶»çÇß½À´Ï´Ù. ¸®´Ï¾î¸¯À» ÀÌ¿ëÇÑ ¿ÜºÎÁ¶»çÄ¡·á(EBRT), ü³»¿¡ ¹æ»ç¼º ¼±¿øÀ» ¼³Ä¡Çϴ ü³»Á¶»çÄ¡·á(Brachytherapy), Àü½ÅÀ» ¼øÈ¯ÇÏ´Â ¹æ»ç¼º ¹°ÁúÀ» ÀÌ¿ëÇÑ Àü½ÅÁ¶»çÄ¡·á µî ´Ù¾çÇÑ ¹æ»ç¼±¿ø°ú Á¶»ç±â¼úÀÌ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹æ»ç¼±Á¾¾çÇÐ ºÐ¾ß´Â ÷´Ü ¿µ»óÁø´Ü, Ä¡·á°èȹ ¼ÒÇÁÆ®¿þ¾î, Àü¹® ÀÇ·áÁö½ÄÀ» ÅëÇÕÇÏ¿© ´Ù¾çÇÑ Á¾¾ç À¯Çü°ú º´±â¿¡ °ÉÄ£ ¾ÏȯÀÚÀÇ Ä¡·á °á°ú¸¦ ÃÖÀûÈ­ÇÕ´Ï´Ù.

ÀÌ ½ÃÀåÀº Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡¿Í ¹æ»ç¼± Á¶»ç ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü¿¡ ÈûÀÔ¾î ±¤¹üÀ§ÇÑ ¹æ»ç¼± Á¾¾çÇÐ Àü¸Á¿¡¼­ Áß¿äÇÑ ºÎ¹®ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå °³¿ä´Â ¹æ»ç¼± Ä¡·á¸¦ °³º° ȯÀÚ ¹× Á¾¾ç Ư¼º¿¡ ¸Â°Ô Á¶Á¤ÇÏ´Â ¸ÂÃã ÀÇ·áÀÇ È®»ê°ú °°Àº ¿äÀο¡ ÀÇÇØ ¿µÇâÀ» ¹Þ´Â ¿ªµ¿ÀûÀΠȯ°æÀ» º¸¿©ÁÝ´Ï´Ù. °­µµº¯Á¶¹æ»ç¼±Ä¡·á(IMRT), ¿µ»óÀ¯µµ¹æ»ç¼±Ä¡·á(IGRT), ¾ç¼ºÀÚÄ¡·á, ÀÚ±â°ø¸íÀ¯µµ¹æ»ç¼±Ä¡·á(MRgRT)¿Í °°Àº ±â¼ú Çõ½ÅÀº Ä¡·áÀÇ Á¤È®¼º°ú È¿°ú¸¦ ³ô¿© ½ÃÀå °³Ã´¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í Àúħ½ÀÀû ¾Ï Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¾Ï ºÐ¾ß ¹æ»ç¼± Ä¡·áÀÇ Àü¹ÝÀûÀÎ ½ÃÀå ¼ºÀå°ú ½ÃÀå ÀáÀç·Â¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¹æ»ç¼± À¯Çüº°·Î º¸¸é, ±¤¹üÀ§ÇÑ ¾ÏÁ¾¿¡ Àû¿ëÇÒ ¼ö ÀÖ°í ÀÌ ±â¼úÀ» °®Ãá Ä¡·á ¼¾ÅͰ¡ ³Î¸® º¸±ÞµÇ¾î Àֱ⠶§¹®¿¡ ¿ÜºÎ ¹æ»ç¼± Ä¡·áÀÌ ÇöÀç ¼¼°è¿¡¼­ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀû Ư¼º°ú È®¸³µÈ ÀÓ»ó ÇÁ·ÎÅäÄÝÀÌ ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ À§Ä¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Ä¡·áº°·Î´Â °­µµº¯Á¶¹æ»ç¼±Ä¡·á(IMRT)°¡ ÇöÀç °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ºöÀÇ °­µµ¸¦ Á¶ÀýÇϸ鼭 Á¾¾çÀÇ ¸ð¾ç¿¡ µû¶ó ¹æ»ç¼±·®À» Á¤È®ÇÏ°Ô Á¶ÀýÇÒ ¼ö Àִ ÷´Ü ±â´ÉÀÌ ´Ù¾çÇÑ ¾Ï Ä¡·á¿¡ ³Î¸® äÅÃµÇ¾î ±¹¼Ò Á¦¾î¸¦ °³¼±ÇÏ´Â È¿°ú°¡ ÀÔÁõµÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º´¿ø ¹× ÀÇ·á ¿¬±¸ ±â°üÀÌ ÇöÀç °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ¹æ»ç¼± Ä¡·á°¡ ±âº» Ä¡·á ¼ö´ÜÀÎ º´¿øÀÌ Á¾ÇÕÀûÀÎ ¾Ï Ä¡·á ¼­ºñ½º¸¦ Á¦°øÇϰí, º´¿øÀÌ ¸¹Àº ȯÀÚ¸¦ Ä¡·áÇϰí, ÀÇ·á ¿¬±¸ ±â°üÀÌ Á¶»ç Ȱµ¿À» ¼öÇàÇϱ⠶§¹®ÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ÇöÀç ¾Ï ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È Á¾¾ç ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾Ï ºÐ¾ß ¹æ»ç¼± Ä¡·á ½ÃÀå¿¡ Àû±ØÀûÀ¸·Î ÁøÃâÇϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ Áß ÀμöµÇÁö ¾ÊÀº ±â¾÷À¸·Î´Â Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG) µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå Á¾¾çÇÐ ¼¼°èÀÇ ¹æ»ç¼± Ä¡·á ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : ¹æ»ç¼± À¯Çüº°

Á¦6Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : Ä¡·áº°

Á¦7Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ¼¼°èÀÇ Á¾¾çÇÐ ¹æ»ç¼± Ä¡·á ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Radiation therapy in the oncology market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Radiation Therapy in the Oncology Market Size, Share, Trends, Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), Therapy, End-User, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Radiation therapy in the oncology market encompasses the utilization of high-energy ionizing radiation to treat and manage cancer. This therapeutic modality involves precisely delivering radiation to malignant tumors, aiming to eradicate cancerous cells or impede their growth while minimizing damage to surrounding healthy tissues and organs. Various radiation sources and delivery techniques are employed, including external beam radiation therapy (EBRT) using linear accelerators, internal radiation therapy (brachytherapy) involving the placement of radioactive sources within the body, and systemic radiation therapy using radioactive substances that circulate throughout the body. The radiation oncology field integrates sophisticated imaging, treatment planning software, and specialized medical expertise to optimize treatment outcomes for cancer patients across diverse tumor types and stages.

The market is a critical segment within the broader radiation oncology landscape, driven by the increasing global incidence of cancer and continuous advancements in radiation delivery technologies. The market overview reveals a dynamic environment influenced by factors such as the growing adoption of personalized medicine, which tailors radiation treatments to individual patient and tumor characteristics. Technological innovations, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy, and magnetic resonance-guided radiation therapy (MRgRT), are enhancing treatment precision and efficacy, thereby fueling market development. Furthermore, the expanding healthcare infrastructure in emerging economies and the rising demand for minimally invasive cancer treatment options contribute significantly to the overall market growth and market potential of radiation therapy in oncology.

Radiation Therapy in the Oncology Market Report Highlights:

By radiation type, the external beam radiation segment currently holds the highest market share globally due to its broad applicability across a wide range of cancer types and the widespread availability of treatment centers equipped with this technology. Its non-invasive nature and established clinical protocols contribute to its dominant position in the radiation therapy market.

By therapy, intensity-modulated radiation therapy (IMRT) presently commands the largest market share. This is primarily because of its advanced capability to precisely conform the radiation dose to the tumor's shape while modulating the beam's intensity, leading to widespread adoption across various cancer treatments and its proven efficacy in improving local control.

By end-user, the hospitals & medical research institutes segment currently accounts for the largest market share. This is mainly due to the comprehensive cancer care services offered by hospitals, where radiation therapy is a fundamental treatment modality, along with the significant patient volumes they handle and the research activities undertaken by medical research institutes.

By region, North America currently holds the largest market share in the radiation therapy in the oncology market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the radiation therapy in the oncology market over the forecast period.

The major players actively involved in the radiation therapy in the oncology market, who have not been acquired, include Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, and Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG).

Polaris Market Research has segmented the Radiation Therapy in the Oncology market report based on radiation type, therapy, end-user, and region:

By Radiation Type Outlook (Revenue - USD Billion, 2020-2034)

External Beam Radiation

Internal Beam Radiation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Stereotactic Radiosurgery (SRS)

Image-Guided Radiation Therapy (IGRT)

Intensity-Modulated Radiation Therapy (IMRT)

Volumetric-Modulated Arc Therapy (VMAT)

Brachytherapy

By End-User Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Medical Research Institutes

Specialized Radiotherapy Centers

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Radiation Therapy in the Oncology Market Insights

5. Global Radiation Therapy in the Oncology Market, by Radiation Type

6. Global Radiation Therapy in the Oncology Market, by Therapy

7. Global Radiation Therapy in the Oncology Market, by End-User

8. Global Radiation Therapy in the Oncology Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â